Aceso Life Science Group Limited (Stock Code: 00474) has scheduled a board meeting on 28 November 2025 at 11:00 a.m. in Wan Chai, Hong Kong. The primary objectives include approving the unaudited interim results for the six months ended 30 September 2025 and considering the possibility of an interim dividend. The meeting will be held at Rooms 2501–2509, 25/F, Shui On Centre, 6–8 Harbour Road.
According to the announcement, the board of directors currently comprises two executive directors, one non-executive director, and three independent non-executive directors. Final decisions regarding interim results adoption and any potential dividend will be disclosed to the public following the meeting as scheduled.